Active Shortage

SUFENTANIL CITRATE INJECTION USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of SUFENTANIL CITRATE INJECTION USP in Canada?

Yes. SUFENTANIL CITRATE INJECTION USP 50MCG has an active shortage reported to Health Canada (last updated August 7, 2026).

Why is SUFENTANIL CITRATE INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will SUFENTANIL CITRATE INJECTION USP be available again?

The manufacturer's estimated resolution date is December 4, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~2 months remaining (estimate)

Affected strength50MCG

Last updated2026-08-07

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SUFENTANIL CITRATE INJECTION USP

SANDOZ CANADA INCORPORATED

50MCG · DIN 02244147

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SUFENTANIL CITRATE INJECTION

HIKMA CANADA LIMITED

50MCG · DIN 02483181

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

SUFENTA INJ 50MCG/ML

JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC.

50MCG · DIN 00619744

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02442213

Strength

50MCG

Dosage Form

SOLUTION

Route

EPIDURAL INTRAVENOUS

Active Ingredient

SUFENTANIL

See all SUFENTANIL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-08-07

Active Shortage

Disruption of the manufacture of the drug.

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890